Triangle Insights

Triangle Insights Group by Mercalis is a strategy consulting firm providing guidance to leaders in life sciences organizations.

[Triangle Insights @TriangleInsight]

This Thanksgiving, we extend our gratitude to our clients, partners, and team members who make our work meaningful. Wishing you a season filled with joy, gratitude, and connection. Happy Thanksgiving from all of us at Triangle Insights Group.

[Triangle Insights @TriangleInsight]

Stay informed on the latest in drug price negotiations under the Inflation Reduction Act. Read more here: https://t.co/jio5ryBVoo
#Pharma #DrugPricing #IRA #Healthcare

[Triangle Insights @TriangleInsight]

Notable developments throughout 2023, such as key approvals, regulatory updates, and advancements defined the year in Cell & Gene Therapy. Check out our recent infographic to stay informed about significant milestones from the past year: https://t.co/mwDHw2Jx4m
#cellandgene #CGT

[Triangle Insights @TriangleInsight]

Mercalis, our parent company shares the success in 2023 including a launch of a corporate rebrand, growth of Triangle Insights Group and Policy Reporter's offerings. Patient Support Services welcomed 75 clients and provided support to 1.6 million patients. https://t.co/yPzMNoUoTa

[Triangle Insights @TriangleInsight]

In our latest white paper, we explore the implications of recently adopted regulatory policies on biopharma organizations that are developing cell and gene therapies. Download now for our insights: https://t.co/4TvDW1WIkv

[Triangle Insights @TriangleInsight]

We are thrilled to announce that TrialCard, the parent company of Triangle Insights Group, has changed its name to Mercalis. The name change reflects the brand’s evolution into an integrated life sciences commercialization partner: https://t.co/QnjX17gQ6o

[Triangle Insights @TriangleInsight]

We are pleased to be taking part in #BioPharmUSA this week. If you would like to discuss how we can support your commercial diligence efforts or strategic consulting needs, please book a meeting with our team via partneringONE: https://t.co/q5vPQKI2dq

[Triangle Insights @TriangleInsight]

Our team is looking forward to a busy conference season. Coming up first are BioPharm America (Sept 13-14) and DTx East (Sept 26-28). To book a meeting, please email [email protected]. We would love to discuss how we can support your commercialization strategy.

[Triangle Insights @TriangleInsight]

We are delighted to announce the promotion of Sarah Jims to Partner at Triangle Insights Group. Congratulations, Sarah, and thank you for your invaluable contribution and commitment to Triangle and our clients. Read more: https://t.co/0TRpezeLAc

[Triangle Insights @TriangleInsight]

Today, we present the results of our 2023 Partnering Performance & Reputation Survey (PPRS). This collates anonymous feedback from biotech execs and business development leaders, with the aim of improving partnering excellence with large pharma: https://t.co/Xir72ssWII

[Triangle Insights @TriangleInsight]

Our latest commentary piece outlines the requirement for a clear strategy to integrate the Inflation Reduction Act (IRA) provisions into a product’s pricing, and the considerations needed for a comprehensive market access strategy. Read more: https://t.co/URmpRfPjeC

[Triangle Insights @TriangleInsight]

Our Partnering Performance & Reputation Survey is now open, collating feedback from biotech execs and business development leaders around their experience of partnering with large pharmaceutical companies. Have your say in this 15-min survey before May 19: https://t.co/QAdLNWVf68

[Triangle Insights @TriangleInsight]

We are here at the 6th Annual Gene Therapy for Rare Disorders Summit in Boston! Email us at [email protected] if you would like to book a meeting with Sarah Jims and Brendan Smith from our team.
https://t.co/RWZY8w7chh

#RareDisease #GeneTherapy

[Triangle Insights @TriangleInsight]

Revenue forecasts for new products carry broad consequences for innovators in pharma and biotech. In this white paper, we highlight learnings from more than 100 examples of revenue forecasting and NPV analyses that we have completed in the past 8 years. https://t.co/9TeoFQr4K4

[Triangle Insights @TriangleInsight]

We are pleased to be an event partner for the 6th Annual Gene Therapy for Rare Disorders Summit, taking place in Boston from March 20-23. If you are attending and would like to connect, email [email protected] to book a meeting with our team.

[Triangle Insights @TriangleInsight]

Our Consulting 180 PhD Program is back for 2023! From April 20-21 at our Durham, NC headquarters, doctoral candidates will have the opportunity to gain a first-hand look into life science consulting with this immersive program. Apply by March 3rd: https://t.co/Hn8Jo2lZtK

[Triangle Insights @TriangleInsight]

During #BlackHistoryMonth, we celebrate the achievements and contributions from our Black colleagues at Triangle Insights Group. Thank you to Serwah Afranie, one of our Associate Consultants, for sharing what this month means to you. https://t.co/V3RS7TuZZS

[Triangle Insights @TriangleInsight]

We're proud to sponsor the #BiotechShowcase this week, where our team has been enjoying connecting with leaders across the life science value chain. If you didn’t catch us, please email [email protected] if you would like to set up a meeting. https://t.co/vstogb7ofD

[Triangle Insights @TriangleInsight]

We are pleased to be at #DermSummit2023 in San Francisco today. If you are in attendance and would like to connect with us, you can still book a meeting by emailing us at [email protected].

#Dermatology #JPM23

[Triangle Insights @TriangleInsight]

We're looking forward to attending the JPM Conference, Biotechnology Showcase & Dermatology Summit in San Francisco. If you're planning to be at #JPM23, let's connect. Book a meeting with us by emailing [email protected] or via partneringONE: https://t.co/fCRTbBduJF